Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen

[1]  A. Beja-Pereira,et al.  Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen , 2013, Malaria Journal.

[2]  Tiago Antao,et al.  A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific , 2013, PloS one.

[3]  Andreas Mårtensson,et al.  Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms , 2012, The Journal of infectious diseases.

[4]  A. S. Bin Ghouth,et al.  Availability and prescription practice of anti-malaria drugs in the private health sector in Yemen. , 2013, Journal of infection in developing countries.

[5]  M. Msellem,et al.  Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar , 2012, Malaria Journal.

[6]  Rod Peakall,et al.  GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research—an update , 2012, Bioinform..

[7]  D. Conway,et al.  Population genetic structure of Plasmodium falciparum across a region of diverse endemicity in West Africa , 2012, Malaria Journal.

[8]  J. Barnwell,et al.  Genetic backgrounds of the Plasmodium falciparum chloroquine resistant transporter (pfcrt) alleles in Pakistan. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[9]  Gauri Awasthi,et al.  Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. , 2012, Memorias do Instituto Oswaldo Cruz.

[10]  N. D. Djadid,et al.  Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran. , 2012, Acta tropica.

[11]  D. Hartl,et al.  The evolutionary landscape of antifolate resistance in Plasmodium falciparum , 2011, Journal of Genetics.

[12]  Ahmed Awad Adeel,et al.  Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications , 2011, Malaria Journal.

[13]  H. Al-Mekhlafi,et al.  High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: An urgent need to re-examine malaria drug policy , 2011, Parasites & Vectors.

[14]  N. Ghanchi,et al.  Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan , 2011, Malaria Journal.

[15]  M. Fong,et al.  Clinical situation of endemic malaria in Yemen. , 2010, Tropical biomedicine.

[16]  M. Salehi,et al.  High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[17]  Teferi Eshetu,et al.  Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia , 2010, Malaria Journal.

[18]  W. Wernsdorfer,et al.  Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan. , 2010, The American journal of tropical medicine and hygiene.

[19]  A. Al-Qahtani,et al.  Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia , 2010, Annals of Saudi medicine.

[20]  O. Müller,et al.  Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso. , 2010, Acta tropica.

[21]  Jung-Mi Kang,et al.  Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar , 2010, Malaria Journal.

[22]  C. Sutherland,et al.  Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates , 2010, Malaria Journal.

[23]  S. Malik,et al.  Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. , 2009, The American journal of tropical medicine and hygiene.

[24]  H. Babiker,et al.  Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[25]  Doaa M Sultan,et al.  Imported malaria in United Arab Emirates: evaluation of a new DNA extraction technique using nested PCR. , 2009, The Korean journal of parasitology.

[26]  Thanat Chookajorn,et al.  Stepwise acquisition of pyrimethamine resistance in the malaria parasite , 2009, Proceedings of the National Academy of Sciences.

[27]  X. Su,et al.  Drug resistance and genetic mapping in Plasmodium falciparum , 2008, Current Genetics.

[28]  N. D. Djadid,et al.  Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. , 2008, The American journal of tropical medicine and hygiene.

[29]  H. Babiker,et al.  High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia. , 2008, International journal for parasitology.

[30]  S. Nadaf,et al.  DETECTION OF K76T MUTATION IN PFCRT GENE AS AN APPLICABLE GENETIC MARKER FOR PREDICTION OF CHLOROQUINE RESISTANT FALCIPARUM MALARIA IN ISOLATES FROM AN ENDEMIC DISTRICT OF IRAN , 2008 .

[31]  H. Al-Shamahy,et al.  The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen , 2007, Annals of Saudi medicine.

[32]  C. Chitnis,et al.  Pfcrt haplotypes and in-vivo chloroquine response in Sundergarh district, Orissa, India. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  S. Krishna,et al.  The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa , 2007, Tropical medicine & international health : TM & IH.

[34]  Alsuhibany Sa.  Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion. , 2007 .

[35]  Saeed A Al Harthi.  Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion. , 2007, Journal of the Egyptian Society of Parasitology.

[36]  M. T. Al-Maktari,et al.  Chloroquine-Resistant Plasmodium falciparum Local Strain in Taiz Governorate, Republic of Yemen , 2006, Chemotherapy.

[37]  P. Smouse,et al.  genalex 6: genetic analysis in Excel. Population genetic software for teaching and research , 2006 .

[38]  H. Ferguson,et al.  Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. , 2005, International journal for parasitology.

[39]  A. Senok,et al.  Status of malaria in the Kingdom of Bahrain: a 10-year review. , 2006, Journal of travel medicine.

[40]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[41]  Abdel-Hameed Aa.  Antimalarial drug resistance in the Eastern Mediterranean Region. , 2003 .

[42]  F. Migot-Nabias,et al.  Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon , 2003, Malaria Journal.

[43]  P. Awadalla,et al.  Local differentiation in Plasmodium falciparum drug resistance genes in Sudan , 2003, Parasitology.

[44]  C. Drakeley,et al.  Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania , 2003, Antimicrobial Agents and Chemotherapy.

[45]  J. Le bras,et al.  Molecular survey of Plasmodium falciparum resistance in south–eastern Iran , 2003, Annals of Tropical Medicine and Parasitology.

[46]  A. Abdel-Hameed.  Antimalarial drug resistance in the Eastern Mediterranean Region. , 2003, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[47]  N. Mühlberger,et al.  Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe , 2002, Malaria Journal.

[48]  John C. Wootton,et al.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.

[49]  P. Awadalla,et al.  The question of Plasmodium falciparum population structure. , 2001, Trends in parasitology.

[50]  D. Warhurst.  A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[51]  X. Su,et al.  A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[52]  H. Babiker,et al.  Genotyping of Plasmodium falciparum gametocytes by reverse transcriptase polymerase chain reaction. , 2000, Molecular and biochemical parasitology.

[53]  J. T. Williams,et al.  Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. , 2000, Molecular biology and evolution.

[54]  J. Wootton,et al.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.

[55]  K. Kirk,et al.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.

[56]  O. Doumbo,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. , 1997, The Journal of infectious diseases.

[57]  J. E. Hyde,et al.  Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization , 1997, Molecular microbiology.

[58]  W. G. Hill,et al.  Estimation of numbers of malaria clones in blood samples , 1995, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[59]  F. Rousset,et al.  Testing heterozygote excess and deficiency. , 1995, Genetics.

[60]  O. Doumbo,et al.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.

[61]  A. Cowman,et al.  Chemotherapy and drug resistance in malaria. , 1990, International journal for parasitology.

[62]  J. E. Hyde,et al.  The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. , 1990, Pharmacology & therapeutics.

[63]  A. Cowman,et al.  Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Marks.  Molecular evolutionary genetics. By M. Nei. New York: Columbia University Press. 1987. x + 512 pp., tables, figures, indexes. $50.00 (cloth) , 1988 .

[65]  M. Nei.  Molecular Evolutionary Genetics , 1987 .

[66]  B S Weir,et al.  Covariances of relatives stemming from a population undergoing mixed self and random mating. , 1984, Biometrics.